Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLenalidomide and Thalidomide are Active in MF-Related Anemia, but Differ in Duration of Response and Association of Benefit with Outcome.AuthorsKuykendall, Andrew; Talati, Chetasi; Padron, Eric; Sweet, Kendra; Sallman, David; List, Alan; Lancet, Jeffrey; Komrokji, RamiPublicationClinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pS350ISSN2152-2650Publication typeArticleDOI10.1016/j.clml.2019.07.363